That buyout was double the market cap. So a $2 billion US price for us, which seems to me to be the floor for a reasonable offer to take to investors, would need our market cap to 5x from here, maybe a little less when the US dollar inevitably weakens. That market cap is very doable within the next year.
What's interesting about the Abiomed acquisition is that there is a sweetener for shareholders. In addition to the price they were offered per share, Abiomed shareholders get a non-tradeable contingent value right that will pay them an additional amount up to about 9% of the value they got for their shares if certain commercial and clinical milestones are achieved.
That buyout was double the market cap. So a $2 billion US price...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
-0.380(2.42%) |
Mkt cap ! $323.4M | |||
| Open | High | Low | Value | Volume |
| $15.70 | $15.94 | $15.02 | $290.0K | 18.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 779 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |